Analysis Of Prescription of National Formularium Medicines Based on The Adjustment of Restriction in Public Hospitals of Sawah Besar 2018

  • Kuncoro Adi Susanto Universitas Pancasila
  • Maura Linda Sitanggang Universitas Pancasila
  • Delina Hasan Universitas Pancasila
  • Ida Chorida Universitas Pancasila
DOI: https://doi.org/10.35814/jifi.v19i1.1056

Abstract

Health services provided to the public in the implementation of the National Health Insurance (NHI) include
promotional, preventive, curative and rehabilitative. In supporting the implementation of NHI, it is necessary
to make eff orts to ensure the availability, aff ordability and accessibility of medicines through the application of the National Formulary (Fornas) as a reference in health services in all health facilities. The purpose of this study was to determine the percentage of prescription drugs in accordance with the National Formulary at Sawah Besar Hospital in 2018. The research design descriptive analysis and data collection was carried out retrospectively in the form of prescribing drugs and from the Hospital Management Information System and Patient Medical Record data. This research was conducted with a sample size of around 19.690 recipes and a length of 6 months of research from July 2018 to December 2018. From the results of the study pattern of prescription writing against the suitability of the National Formulary was 71.22%. Compatibility of 75% antihyperlipidemic drugs with atorvastatin as the drug with the most non-conformity of restrictions. The conformity of antihypertension drugs 54.11% with Valsatran as one of the inconsistencies in restriction and insulin drugs, 70.03% the antihyperglycemia drug restriction inconsistencies.

References

1. Keputusan Menteri Kesehatan Nomor HK.01.07/MENKES/422/2017 tentang Rencana Strategis
Kementerian Kesehatan Tahun 2015 – 2019. Jakarta: Kementerian Kesehatan RI. 2017.

2. Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.02.02/MENKES/524/2015 Tentang
Pedoman Penyusunan dan Penerapan Formularium Nasional. 2015.

3. Kementerian Kesehatan Republik Indonesia. Laporan akuntabilitas kinerja 2017. Jakarta. Kemkes RI: 2017.

4. Winda Syahdu. Formularium Nasional dan e-catalog obat sebagai upaya pencegahan korupsi dalam tata
kelola obat Jaminan kesehatan nasional(JKN). Jakarta: Integritas; 2018, volume 4 nomor 2.

5. Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/MENKES/707/2018. Tentang
Perubahan atas Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/MENKES/659/2017
tentang Formularium Nasional; 2019.

6. Anonim. Infodatin, Pusat data dan informasi Kementerian Kesehatan Republik Indonesia: 2018.

7. Kementerian Kesehatan RI. Undang- Undang Republik Indonesia Nomor 72 tahun 2016 tentang Standar
Pelayanan Kefarmasian. Jakarta: 2016.

8. Keputusan Menteri Kesehatan Republik Indonesia Nomor 129/Menkes/SK/II/2008 tentang Standar
Pelayanan Minimal di Rumah Sakit; 2008.

9. Tim biomedis Riset Kesehatan Dasar, Badan Penelitian dan Pengembangan Kesehatan Kementerian Kesehatan Republik Indonesia. Laporan Riset Kesehatan dasar (Riskesdas) Bidang Biomedis. 2018.
Published
2021-04-29
How to Cite
SUSANTO, Kuncoro Adi et al. Analysis Of Prescription of National Formularium Medicines Based on The Adjustment of Restriction in Public Hospitals of Sawah Besar 2018. JURNAL ILMU KEFARMASIAN INDONESIA, [S.l.], v. 19, n. 1, p. 68-72, apr. 2021. ISSN 2614-6495. Available at: <http://jifi.farmasi.univpancasila.ac.id/index.php/jifi/article/view/1056>. Date accessed: 09 may 2025. doi: https://doi.org/10.35814/jifi.v19i1.1056.
Citation Formats
Issue
Vol 19 No 1 (2021): JIFI
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Licencing
All articles in Jurnal Ilmu Kefarmasian Indonesia are an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted non-commercial used, distribution and reproduction in any medium.

This licence applies to Author(s) and Public Reader means that the users mays :

  • SHARE:
    copy and redistribute the article in any medium or format
  • ADAPT:
    remix, transform, and build upon the article (eg.: to produce a new research work and, possibly, a new publication)
  • ALIKE:
    If you remix, transform, or build upon the article, you must distribute your contributions under the same license as the original.
  • NO ADDITIONAL RESTRICTIONS:
    You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

It does however mean that when you use it you must:

  • ATTRIBUTION: You must give appropriate credit to both the Author(s) and the journal, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

You may not:

  • NONCOMMERCIAL: You may not use the article for commercial purposes.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.